ES2080727T3 - Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos. - Google Patents
Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos.Info
- Publication number
- ES2080727T3 ES2080727T3 ES89100392T ES89100392T ES2080727T3 ES 2080727 T3 ES2080727 T3 ES 2080727T3 ES 89100392 T ES89100392 T ES 89100392T ES 89100392 T ES89100392 T ES 89100392T ES 2080727 T3 ES2080727 T3 ES 2080727T3
- Authority
- ES
- Spain
- Prior art keywords
- manufacture
- quinolizinone
- quinolizin
- medicines
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA PRESENTE INVENCION EXPONE EL USO DE QUINOLIZINE Y SUS DERIVADOS EN LA FABRICACION DE UN MEDICAMENTO PARA TRATAMIENTO DE ANSIEDAD, PSICOSIS, GLAUCOMA Y SIMULAR MOVILIDAD GASTRICA. LA INVENCION TAMBIEN EXPONE CIERTOS DERIVADOS DE QUINOLIZINA Y QUINOLIZINA QUE SON UTILES PARA LOS SUPUESTOS INDICADOS ANTES QUE SON TAMBIEN UTILES PARA EL TRATAMIENTO DE JAQUECA Y NAUSEAS Y VOMITOS.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88400417A EP0329904A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety |
EP88400415A EP0329902A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis |
EP88400418A EP0329905A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility |
EP88400416A EP0329903A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma |
US18563188A | 1988-04-26 | 1988-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2080727T3 true ES2080727T3 (es) | 1996-02-16 |
Family
ID=27513624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89100392T Expired - Lifetime ES2080727T3 (es) | 1988-02-23 | 1989-01-11 | Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0329932B1 (es) |
JP (1) | JPH02288880A (es) |
KR (1) | KR890013018A (es) |
AT (1) | ATE129153T1 (es) |
AU (1) | AU624115B2 (es) |
DE (1) | DE68924545T2 (es) |
DK (1) | DK175643B1 (es) |
ES (1) | ES2080727T3 (es) |
GR (1) | GR3018299T3 (es) |
IE (1) | IE72504B1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990012569A1 (en) * | 1989-04-21 | 1990-11-01 | Sandoz Ag | Therapeutic use of 5-ht3 receptor antagonists |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
US5508287A (en) * | 1992-02-24 | 1996-04-16 | Merrell Pharmaceuticals Inc. | 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist |
HU216831B (hu) * | 1992-02-24 | 1999-09-28 | Merrel Dow Pharmaceuticals Inc. | Eljárás 5-HT3-receptor antagonista 2,6-metano-2H-kinolizin-származék és az ezt tartalmazó gyógyszerkészítmény előállítására |
US8163916B2 (en) * | 2007-03-23 | 2012-04-24 | Abbott Laboratories | Azaadamantane ester and carbamate derivatives and methods of use thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI74707C (fi) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror. |
DE3429830A1 (de) * | 1983-08-26 | 1985-03-07 | Sandoz-Patent-GmbH, 7850 Lörrach | Automatische carbonsaeure- und sulfonsaeureester oder -amide |
DE3445377A1 (de) * | 1983-12-23 | 1985-07-04 | Sandoz-Patent-GmbH, 7850 Lörrach | Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen |
AU583343B2 (en) * | 1985-01-23 | 1989-04-27 | Glaxo Group Limited | Heterocyclic compounds |
EP0201165B1 (en) * | 1985-03-14 | 1994-07-20 | Beecham Group Plc | Medicaments for the treatment of emesis |
GB8525913D0 (en) * | 1985-10-21 | 1985-11-27 | Beecham Group Plc | Compounds |
GB8511988D0 (en) * | 1985-05-11 | 1985-06-19 | Beecham Group Plc | Compounds |
GB8520616D0 (en) * | 1985-08-16 | 1985-09-25 | Beecham Group Plc | Compounds |
GB8523211D0 (en) * | 1985-09-19 | 1985-10-23 | Beecham Group Plc | Compounds |
EP0220011A3 (en) * | 1985-10-12 | 1990-01-03 | Beecham Group Plc | Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia |
US4910193A (en) * | 1985-12-16 | 1990-03-20 | Sandoz Ltd. | Treatment of gastrointestinal disorders |
ZA878096B (en) * | 1986-11-03 | 1988-04-26 | Merrell Dow Pharmaceuticals Inc. | Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds |
EP0330788A1 (en) * | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia |
-
1989
- 1989-01-11 EP EP89100392A patent/EP0329932B1/en not_active Expired - Lifetime
- 1989-01-11 ES ES89100392T patent/ES2080727T3/es not_active Expired - Lifetime
- 1989-01-11 AT AT89100392T patent/ATE129153T1/de not_active IP Right Cessation
- 1989-01-11 DE DE68924545T patent/DE68924545T2/de not_active Expired - Lifetime
- 1989-02-22 KR KR1019890002061A patent/KR890013018A/ko not_active Application Discontinuation
- 1989-02-22 AU AU30214/89A patent/AU624115B2/en not_active Expired
- 1989-02-22 DK DK198900809A patent/DK175643B1/da not_active IP Right Cessation
- 1989-02-22 IE IE56489A patent/IE72504B1/en not_active IP Right Cessation
- 1989-02-23 JP JP1042012A patent/JPH02288880A/ja active Pending
-
1995
- 1995-12-05 GR GR950403417T patent/GR3018299T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE890564L (en) | 1989-08-23 |
DK80989A (da) | 1989-08-24 |
JPH02288880A (ja) | 1990-11-28 |
AU624115B2 (en) | 1992-06-04 |
DE68924545D1 (de) | 1995-11-23 |
DK175643B1 (da) | 2005-01-03 |
EP0329932A3 (en) | 1992-08-05 |
AU3021489A (en) | 1989-08-24 |
DE68924545T2 (de) | 1996-03-21 |
DK80989D0 (da) | 1989-02-22 |
EP0329932B1 (en) | 1995-10-18 |
IE72504B1 (en) | 1997-04-23 |
ATE129153T1 (de) | 1995-11-15 |
EP0329932A2 (en) | 1989-08-30 |
GR3018299T3 (en) | 1996-03-31 |
KR890013018A (ko) | 1989-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO875378D0 (no) | Fremgangsmaate for fremstilling av grannlocyttstimulerende faktor (polypeptidderivater). | |
NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
NO166362C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater. | |
ZA867495B (en) | Novel polyoxgenated labdane derivatives,processes for their preparation and their use as medicaments | |
ES2080727T3 (es) | Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos. | |
FI884660A (fi) | Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi | |
IT8921893A0 (it) | Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature. | |
DK430689D0 (da) | 2-aza-4-(alkoxycarbonyl)spiro(4,5)decan-3-oner | |
DE3865073D1 (de) | Imidazopyridinderivate, ihre herstellung und therapeutische verwendung. | |
PT90716A (pt) | Processo aperfeicoado para a preparacao de derivados de ariloxipropanolamina uteis como antagonistas de serotonina | |
ES2111561T3 (es) | Derivados de benzopirano antihipertensivos. | |
NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
ATE112168T1 (de) | Menschlicher hitzeschock-faktor. | |
DK429788A (da) | Thieno(2,3-beta)thiophen-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse | |
NO891025L (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktivesialosylglycerider. | |
FR2530246B1 (fr) | Nouveaux derives pyrido indoliniques et pirido indoliques et leurs sels, ainsi que le procede de preparation et l'application en therapeutique de ces derives et sels | |
PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
PT87821A (pt) | Process for the preparation of 10-propyl-2,8-bis(1h-tetrazol-5-il)-4h,6h-benzo(1,2-b;5,4-b)dypiran-4,6-dione of calcium | |
ES2043896T3 (es) | Procedimiento para la preparacion de derivados de tetrahidropiridina. | |
ES2013877A6 (es) | Nuevo procedimiento para producir derivados de imidazopiridina. | |
NO904154L (no) | Terapeutisk anvendbare tetralinderivater. | |
IT8822478A0 (it) | Procedimento per la preparazione della n (2,6 diclorofenil) n feniln (cloroacetil) ammina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 329932 Country of ref document: ES |